Pamela Bacon

663 total citations
22 papers, 490 citations indexed

About

Pamela Bacon is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Pamela Bacon has authored 22 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Pamela Bacon's work include Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (7 papers) and Neutropenia and Cancer Infections (6 papers). Pamela Bacon is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Cancer Treatment and Pharmacology (7 papers) and Neutropenia and Cancer Infections (6 papers). Pamela Bacon collaborates with scholars based in United Kingdom, Switzerland and Germany. Pamela Bacon's co-authors include David Menon, Hugh Cowley, Helen F. Goode, Nigel R. Webster, J. G. Jones, Matthias Schwenkglenks, Hermann Einsele, Dietger Niederwieser, Shaun R. McCann and Samuel Vokurka and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

Pamela Bacon

19 papers receiving 471 citations

Peers

Countries citing papers authored by Pamela Bacon

Since Specialization

Citations

This map shows the geographic impact of Pamela Bacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela Bacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela Bacon more than expected).

Fields of papers citing papers by Pamela Bacon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela Bacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela Bacon. The network helps show where Pamela Bacon may publish in the future.

Co-authorship network of co-authors of Pamela Bacon

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela Bacon. A scholar is included among the top collaborators of Pamela Bacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela Bacon. Pamela Bacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide 2020 ·Clinical Lymphoma Myeloma & Leukemia ·Barbara Gamberi, Christian Berthou, Miguel‐Teodoro Hernández, Gianpietro Semenzato, Eleni Tholouli, Roman Hájek, Jo Caers, Meletios Α. Dimopoulos, Monique C. Minnema, Björn Andréasson, (unknown), (unknown), Kari Remes, (unknown), (unknown), (unknown), Sarah Peters, Pamela Bacon, Igor Wolfgang Blau	1
2	Safety in Patients with Multiple Myeloma Treated with Pomalidomide in a Real-World Setting According to Last Prior Treatment: A European Post-Authorization Safety Study 2018 ·Blood ·Niels Abildgaard, Marie‐Christiane Vekemans, Barbara Gamberi, Francesco Di Raimondo, Ángel Ramírez Páyer, Charalampia Kyriakou, Alain Kentos, (unknown), (unknown), (unknown), Pamela Bacon, (unknown), Torben Plesner	1
3	Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial 2018 ·Journal of Clinical Oncology ·Meletios Α. Dimopoulos, Katja Weisel, Niels W.C.J. van de Donk, Karthik Ramasamy, Barbara Gamberi, Matthew Streetly, Massimo Offidani, Frank Bridoux, Javier de la Rubia, María‐Victoria Mateos, Antonio Ardizzoia, (unknown), (unknown), (unknown), (unknown), Yan Li, Pamela Bacon, Pieter Sonneveld	38
4	MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis 2017 ·Blood ·Pieter Sonneveld, Katja Weisel, Yan Li, (unknown), (unknown), (unknown), (unknown), Pamela Bacon, Meletios Α. Dimopoulos	2
5	Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis 2017 ·Clinical Lymphoma Myeloma & Leukemia ·Katja Weisel, Meletios Α. Dimopoulos, Niels W.C.J. van de Donk, Karthik Ramasamy, Barbara Gamberi, Matthew Streetly, Massimo Offidani, Frank Bridoux, Javier de la Rubia, (unknown), (unknown), Frederik Lersch, (unknown), Pamela Bacon, Pieter Sonneveld	1
6	European Post-Approval Safety Study (PASS) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including SPM, in a Large Cohort of Patients Treated with Lenalidomide, Thalidomide, and Bortezomib 2016 ·Blood ·Barbara Gamberi, Miguel‐Teodoro Hernández, Christian Berthou, Eleni Tholouli, Elena Zamagni, Roman Hájek, Monique C. Minnema, Meletios Α. Dimopoulos, Jo Caers, Niels Frost Andersen, Björn Andréasson, Anders Waage, (unknown), (unknown), (unknown), (unknown), Pamela Bacon, Igor Wolfgang Blau	0
7	European Post-Approval Safety Study (Registry) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety of Patients Treated with Pomalidomide 2016 ·Blood ·Francesco Di Raimondo, Charalampia Kyriakou, Martin Schmidt‐Hieber, Marie‐Christiane Vekemans, Ángel Ramírez Páyer, (unknown), Birgitta Lauri, (unknown), Frederik Lersch, (unknown), Pamela Bacon, Torben Plesner	0
8	Safety of Treatment (Tx) with Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Patients (Pts) with Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI), Including Those on Dialysis 2015 ·Blood ·Karthik Ramasamy, Meletios Α. Dimopoulos, Niels W.C.J. van de Donk, Barbara Gamberi, Frank Bridoux, Matthew Streetly, (unknown), (unknown), (unknown), Frederik Lersch, Pamela Bacon, Katja Weisel, Pieter Sonneveld	5
9	Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma 2015 ·Blood ·Charalampia Kyriakou, Philip Murphy, Maria Teresa Petrucci, Pamela Bacon, Philip Lewis, Hélène Gilet, Benoît Arnould, Isabelle Vande Broek, Xavier Leleu	0
10	MM-013: An ongoing phase 2 trial of pomalidomide and low-dose dexamethasone (POM + LoDEX) in relapsed/refractory multiple myeloma (RRMM) with moderate or severe renal impairment (RI) including patients (pts) undergoing hemodialysis. 2014 ·Journal of Clinical Oncology ·Pieter Sonneveld, Nils Heyne, (unknown), Axel Glasmacher, Claudia Kasserra, (unknown), Pamela Bacon, Katja Weisel	5
11	Continued Treatment Duration, Drug dosing and Health-Related Quality Of Life (HRQoL) Of Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving 2nd and 3rd Line Treatments: Results From a European Multicentre Study 2013 ·Blood ·Maria Teresa Petrucci, Xavier Leleu, Charalampia Kyriakou, Isabelle Vande Broek, Philip Murphy, Philip Lewis, Pamela Bacon, Benoît Arnould, Manfred Welslau	1
12	Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM) 2013 ·Blood ·Xavier Leleu, Maria Teresa Petrucci, Manfred Welslau, Isabelle Vande Broek, Philip Murphy, Andrew Bottomley, Pamela Bacon, Philip Lewis, Hélène Gilet, Benoît Arnould, Charalampia Kyriakou	5
13	The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: Findings from clinical practice 2012 ·Leukemia Research ·Antonio Salar, Corinne Haïoun, Francesca Gaia Rossi, Ulrich Duehrsen, Ruth Pettengell, Hans Erik Johnsen, Ulrich Jaeger, Gregor Verhoef, Matthias Schwenkglenks, Pamela Bacon, (unknown), Pieternella J. Lugtenburg	32
14	Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments in Patients with Relapsed or Refractory Multiple Myeloma 2011 ·Blood ·Michèle Cavo, Luciano Masini, Igor Wolfgang Blau, Miguel‐Teodoro Hernández, Renato Zambello, Paolo de Fabritiis, Christian Berthou, Argiris Symeonidis, Jennifer M. Bird, Javier de la Rubia, Pamela Bacon, (unknown), (unknown), Neil Minton	1
15	Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy 2009 ·Critical Reviews in Oncology/Hematology ·Matti Aapro, Matthias Schwenkglenks, Gary H. Lyman, Antonio López–Pousa, (unknown), Tomáš Skácel, Pamela Bacon, Gϋnter von Minckwitz	26
16	Febrile Neutropenia Risk Assessment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens. 2009 ·Blood ·Antonio Salar, Corinne Haïoun, Francesca Gaia Rossi, Ulrich Duehrsen, Ruth Pettengell, Hans Erik Johnsen, Ulrich Jaeger, Gregor Verhoef, Matthias Schwenkglenks, (unknown), Pamela Bacon, (unknown), Pieternella J. Lugtenburg	5
17	Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study. 2006 ·PubMed ·Andreas Engert, Henning Bredenfeld, Hartmut Döhner, Anthony D. Ho, Norbert Schmitz, Dietmar Berger, Pamela Bacon, Tomáš Skácel, Valerie Easton, Volker Diehl	24
18	Pegfilgrastim Supports Delivery of CHOP-R Chemotherapy Administered Every 14 Days: A Randomised Phase II Study. 2004 ·Blood ·Andrés López, Alberto Fernández de Sevilla, Sylvie Castaigné, Richard Greil, Jorge Sierra, (unknown), Valerie Easton, Pamela Bacon	15
19	Plasma Antioxidant Consumption Associated With Ischemia/Reperfusion During Carotid Endarterectomy 1996 ·Stroke ·Pamela Bacon, Shirley Love, Arun Kumar Gupta, Peter J. Kirkpatrick, David Menon	19
20	Plasma antioxidant potential in severe sepsis 1996 ·Critical Care Medicine ·Hugh Cowley, Pamela Bacon, Helen F. Goode, Nigel R. Webster, J. G. Jones, David Menon	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact